BLACK FRIDAY DEALS ON COURSES AND THE CROSSFIT STORE

Monday

190819

Statins — Are the Data Free From Bias?

Dr. Malcolm Kendrick discusses recent concerns in the medical community regarding the potential for bias in clinical research on statin therapy. He reviews the various reasons statin trials may be unreliable, including selective publication of results and strategic shifting of trial endpoints during ongoing studies. Despite the apparent evidence-based support of statin therapy and measures taken in the 1990s and early 2000s to mitigate bias, Kendrick urges doctors to proceed with caution when recommending the drugs. Echoing another review from 2015, Kendrick claims “a complete reassessment [of their efficacy and safety] is mandatory.”

Read MoreStatins — Are the Data Free From Bias?